New skincare combo may fade dark spots in skin of color
NCT ID NCT06938815
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special skincare routine to treat and prevent dark spots that appear after inflammation in people with darker skin tones. Ten adults with post-inflammatory hyperpigmentation used a peel and other products for 12 weeks. The goal was to see if the regimen improved their skin and satisfaction with their appearance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men and women ages 18+. * Clinical diagnosis of Post Inflammatory Hyperpigmentation * Non-Caucasian * Fitzpatrick skin types IV-VI * Available and willing to comply with study instructions and attend all study visits. * Able and willing to provide written and verbal informed consent. Exclusion Criteria: * Subject has any skin pathology or condition that could interfere with the evaluation of the test products or requires the use of interfering topical or systemic therapy. * Caucasian/ Non-Hispanic * Subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study. * Pregnant, lactating, or is planning to become pregnant during the study. * Subject is currently enrolled in an investigational drug or device study. * Subject has received an investigational drug or has been treated with an investigational device within 30 days prior to the initiation of treatment (baseline). * Study participant has facial hair that could interfere with the study assessments in the opinion of the investigator. * Study participant is unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function. * Subject has known hypersensitivity or previous allergic reaction to any of the active or inactive components of the test articles. * Subject has the need or plans to be exposed to artificial tanning devices or excessive sunlight during the trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Post-inflammatory hyperpigmentation are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New York Harbor VA Brooklyn Campus
Brooklyn, New York, 11209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.